AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 18 filers reported holding AZURRX BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,000 | +50.0% | 6,250 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $4,000 | -71.4% | 6,250 | -59.0% | 0.00% | -80.0% |
| Q2 2020 | $14,000 | +250.0% | 15,250 | +96.8% | 0.01% | +150.0% |
| Q1 2020 | $4,000 | -50.0% | 7,750 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $8,000 | +100.0% | 7,750 | +24.0% | 0.00% | +50.0% |
| Q3 2019 | $4,000 | -42.9% | 6,250 | +43.7% | 0.00% | -33.3% |
| Q2 2019 | $7,000 | -12.5% | 4,350 | +40.3% | 0.00% | -25.0% |
| Q1 2019 | $8,000 | – | 3,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARSONS CAPITAL MANAGEMENT INC/RI | 434,783 | $1,117,000 | 0.12% |
| J. Goldman & Co LP | 425,358 | $1,093,000 | 0.08% |
| 683 Capital Management, LLC | 400,000 | $1,028,000 | 0.07% |
| ARDSLEY ADVISORY PARTNERS LP | 150,000 | $386,000 | 0.05% |
| GILDER GAGNON HOWE & CO LLC | 556,537 | $1,430,000 | 0.02% |
| TIEDEMANN ADVISORS, LLC | 60,000 | $154,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 131,456 | $338,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 22,780 | $59,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | $1,285,000 | 0.00% |
| Rockefeller Capital Management L.P. | 16,971 | $44,000 | 0.00% |